The Advisory Committee is an esteemed group of industry thought leaders assembled by BIO to shape this event’s conference program by collaboratively identifying topics and speakers that will facilitate engaging and informative discussions.
Gad Berdugo
Managing Partner, Explorium Capital LLC
Rajeev Dadoo, PhD
COO and Managing Partner of SR One
Rich Daly
President, Global Rare Disease, Angelini Pharma
Michelle Doig
Partner, Head of Corporate Development, Omega Funds
Chris Garabedian
CEO, Xontogeny
Mark Glickman
CEO, BioFlorida
Sara Nayeem, MD
Independent Consultant
Marta New, PhD, MBA
Chief Strategy Officer, LevelSet Bio
Carolyn Ng, PhD
Partner and Managing Director, TPG Life Sciences Innovations
John Norris
Managing Director, HSBC Innovation
Philip S. Ross, MD
Chairman Global Healthcare, Investment Banking, Jefferies
Jennifer Sheng
Managing Director, Head of Healthcare Equity Capital Markets
Chidozie Ugwumba
Founder & Managing Partner, SymBiosis
Asish Xavier, PhD
Chief Strategy & Operations Office and Vice President, Venture Investments, Johnson & Johnson Innovation- JJDC